Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
3
50%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

Completed2
unknown2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (100.0%)

Trials by Status

terminated117%
completed233%
recruiting117%
unknown233%

Recent Activity

1 active trials
Showing 5 of 6
recruiting

Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

NCT04367883
terminatedphase_4

Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

NCT03686696
completed

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

NCT04467931
unknownphase_4

Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy

NCT02981212
unknownphase_4

Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

NCT01377285
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04367883

Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

Recruiting
NCT03686696Phase 4

Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

Terminated
NCT04467931

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Completed
NCT02981212Phase 4

Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy

Unknown
NCT01377285Phase 4

Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

Unknown
NCT02215733

The Use of Angiotensin Receptor Blockers and the Risk of Cancer

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6